Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells.
Cancer cells are characterized by the Warburg effect, a shift from mitochondrial respiration to oxidative glycolysis. We report here the crucial role of cyclin D1 in promoting this effect in a cyclin-dependent kinase (CDK)4/6-independent manner in multiple myeloma (MM) cells. We show that the cyclin D1 oncoprotein targets hexokinase 2 (HK2), a major glycolysis regulator, through two original molecular mechanisms in the cytoplasmic and nuclear compartments.
- Ref: DOI : 10.1038/s41389-020-00253-3
- Année de publication : 2020
- Auteurs : Caillot M, Bourgeais J, Dakik H, Costé É, Mazure NM, Lelièvre É, Coqueret O, Hérault O, Mazurier F, Sola B.
- Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »